TODAY’S NEWS
Pfizer‘s oncology drug Sutent slows down pancreatic cancer spread – Pfizer Inc. said Sutent, its drug for kidney cancer, also helps stop the progression of a kind of pancreatic cancer, according to a late-stage trial. Sutent is in several late-stage studies to investigate expanding its use beyond kidney and gastrointestinal treatment, exploring its efficacy in treating breast and lung cancer, among others. In the most recent study of patients with advanced tumors originating in the hormone-production area of the pancreas, disease progression was halted for more than twice as long with Sutent versus a placebo..more
Quintiles re-brands: Navigating the New Health.
In pharma-world, people often joke about how we should just put statins in the drinking water. Here’s some insight as to why (don’t shoot the messenger – I know there are plenty of detractors!)
Doc gives up hospital post over conflict-of-interest rules.
RECOMMENDED
Business Acumen – We have partners who will help your leaders and individual contributors acquire and analyze industry, market, operational and financial information, and apply insights from that analysis to develop strategies and make better business decisions. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.
PLUS
Prilosec making a big venture into social media: a good move? – Procter & Gamble has launched a new online social media site for Prilosec OTC focused on winning new customers by talking up the lifestyle difficulties of heartburn sufferers. In an increasingly crowded market for over-the-counter heartburn medicines, is it worth spending millions more on an advertising campaign for a mature product with declining sales volumes? …more
JUST FOR FUN
———-
Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)
Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)
Connect with Steve Woodruff
Hi Steve–I think the “millions” number for Prilosec’s OTC SM campaign is David Phillips’ (BNet) hyperbole rather than a real number. Unless P&G plans on “sponsoring” a huge number of Prilosec users -or- there’s a massive media spend associated with it, this is (or should be) a six-figure effort.
Best,
Bart